Stock Track | Tronox Plunges 10.31% Following Disappointing Q2 Results and Significant Net Loss

Stock Track
Jul 31, 2025

Tronox Holdings (NYSE: TROX), a leading manufacturer of titanium dioxide pigment, saw its stock plummet 10.31% on Thursday following the release of its disappointing second-quarter 2025 financial results. The company's performance fell short of analyst expectations across multiple key metrics, raising concerns about its near-term prospects.

According to the earnings report, Tronox posted a revenue of $731 million for the quarter, significantly below the $781 million forecast by analysts and marking an 11% decrease year-over-year. The company reported a net loss of $85 million, a stark contrast to the $16 million net income recorded in the same period last year. Adjusted earnings per share (EPS) showed a loss of $0.28, considerably worse than the anticipated loss of $0.05 per share.

Further compounding investor concerns, Tronox's adjusted EBITDA came in at $93 million, well below the expected $109.1 million, with an adjusted EBITDA margin of 12.7%. The company attributed the decline to lower sales volumes, increased production and freight costs, and lower average selling prices. Additionally, Tronox reported $39 million in restructuring and other charges, primarily related to the idling of its Botlek pigment plant. With total debt standing at $3.1 billion and a net leverage ratio of 6.1x, the company's financial position has raised eyebrows among investors, contributing to the sharp sell-off during the trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10